Skip to main content
. 2012 Apr 17;33(7):1270–1276. doi: 10.1093/carcin/bgs148

Table II.

Highly mutated genes and their associated pathways in lung cancer

Set Regulatory process or pathway Representative altered genes Adjusted P values
Common DNA damage control TP53, MYO5A,POT1, DAXX, RB1, NBN 2E-14
c-jun N-terminal kinase signaling TP53, DAXX, PLCB1, PIK3CG, ATF2 3E-21
Role of SUMO in p53 regulation TP53, DAXX 5E-20
Hepatocyte growth factor signaling in pancreatic cancer TP53, HGF 2E-18
Transforming growth factor-beta signaling TP53, ATF2 5E-12
ADC Mitogen-activated protein kinase signaling KRAS and NOX4 3E-04
SCC Invasion DDI1, PROC, MMP16, HSPA6, PCCB, LCT and AOX1 2E-03
Small GTPase signaling WNK1, PLCXD3, PREX2, FMN2, DAB1 and CD36 5E-03
ECM remodeling LAMB1 and MMP16 7E-04